期刊文献+

24h动态血压监测评价卡维地洛对原发性高血压患者的降压效应

The Efficacy of Carvedilol in Primary Hypertenson Assessed by Twenty-four Hour Ambulatory Blood Pressure Montoring
下载PDF
导出
摘要 目的 :评价卡维地洛对原发性高血压患者的降压效应。方法 :选择我科 2 0 0 3年 7月至 2 0 0 4年 1月住院的原发性高血压患者 4 2例 ,行首次 2 4 h动态血压监测后开始服用卡维地洛 ,初始剂量为 12 .5 mg,每日口服 1次。治疗开始后每日服药前测卧位血压 1次 ,若血压控制不满意 ,可根据病情增加剂量。 4周结束时重复行 2 4 h动态血压监测。治疗前和治疗 4周结束时行血、尿常规、肝肾功能、血脂、血电解质、空腹血糖等检查。结果 :经 4周卡维地洛治疗后 ,显效 37例 (88.10 % ) ,有效 4例 (9.5 2 % ) ,无效 1例 (2 .38% ) ,总有效率 (97.6 2 % )。治疗后患者平均收缩压(SBP)、平均舒张压 (DBP)谷峰比值分别为 6 3%和 6 5 %。结论 :本观察发现卡维地洛降压疗效确切 ,有效率为 97.6 2% ,有满意的谷 /峰比值 ,副作用少 ,是一种很有前途的新型抗高血压药物。 Objective To assess the antihypertensive efficacy of carvedilol.Methods choseforty-two hypertension patients who admitted our division during July 2003~Jan.2004.Took orallycarvedilol after tested ABPM(Ambulatory blood pressure monitoring). The initials dosage was 12.5 mg one time a day.Before took orally Carvedilo1 every day, tested blood pressure one time after treatment Was begun.If blood pressure was still high the dosage could be added.After four weeks tested ABPMagain.It is performed that blood routine examination,hepatic function,renal function,blood electrolure,blood lipoprotein,blood sugar on an empty stomach on pretreatment,and four weeks after treatment.Results After four weeks treatment,the marked effective rate was 88.10 %,the effective rate was 9.52 %,the inefficiency rate was 2.38 %.The total effective rate wsa 97.62 %.After treatment the rate of ravine/cusp of SBPand DBP was 63 % and 65 %.Conclusion The antihypertensive efficacy of carvedilol is a new type depressor.
机构地区 西安市中心医院
出处 《实用医技杂志》 2004年第07A期1141-1142,共2页 Journal of Practical Medical Techniques
关键词 24H动态血压 卡维地洛 原发性高血压 降压效应 降压药物 Primary hypertension ABPM Carvedilol
  • 相关文献

参考文献2

二级参考文献16

  • 1罗雪琚,杜传礼.降压谷峰值比率的临床应用[J].心血管病学进展,1996,17(1):8-10. 被引量:14
  • 2吕云清 高润泉.全国1979年高血压抽样普查的初步总结[J].中华心血管病杂志,1980,8(3):165-165.
  • 3张白钠 赵光胜.近年来我国在高血压病研究工作的初步成果[J].中华内科杂志,1960,8:100-100.
  • 4Neutel JM. The importance of 24-h blood pressure control[J]. Blood Pressure Monitoring, 2001.6:9-16.
  • 5Ingelfinger JR. Ambulatory blood pressure momitoring as a predictive tool [J].New Engl J Med ,2002,347:778-779.
  • 6Meredith PA, Elliott HL. FDA guidelines on trough : peak ratios in the evaluation of antihypertensive asents. United States Food and Drug Administration [J]. J Cardiovasc Pharmacol, 1994,23 ( suppi 5 ) : S26-S30.
  • 7Omboni S, Fogari R, Palatini P, et al. Reproducibility trod clinical value of the trough-to peak ratio of the antihyperteensive effect :evidence from the sample study[J]. Hypertension,1998,32(3) :424-429.
  • 8Parati G,Omboni S. Rizzoni D,et ad. The smoothness iadex: a new, reproducible and clinically relevamt messure of the homopneity of the blood pressure reduction with treatment for hypertension [ J ]. J Hypertens, 1998.16 : 1685-1 691.
  • 9Mancia G,Omboni S, Agabiti-Rosei E,et al. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetio patieuts[J]. J Cardiovasc Pharmacol ,2000.35 (6) :926-931.
  • 10Omboni S,Parati G,Mancia G. The trough: pesk ratio and smoothancess index in the evaluation of control of 24h blood pressure by treatment in hypertension[J].Blood press Monit,1998.3(3):201-204.

共引文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部